SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001140361-21-015372
Filing Date
2021-04-30
Accepted
2021-04-30 17:16:13
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1 nt10023650x1_s1.htm S-1 509010
2 EXHIBIT 4.1 nt10023650x1_ex4-1.htm EX-4.1 1635
3 EXHIBIT 4.2 nt10023650x1_ex4-2.htm EX-4.2 19460
4 EXHIBIT 5.1 nt10023650x1_ex5-1.htm EX-5.1 8514
5 EXHIBIT 10.9(A) nt10023650x1_ex10-9a.htm EX-10.9(A) 6118
6 EXHIBIT 21.1 nt10023650x1_ex21-1.htm EX-21.1 3143
7 EXHIBIT 23.1 nt10023650x1_ex23-1.htm EX-23.1 2567
8 EXHIBIT 23.2 nt10023650x1_ex23-2.htm EX-23.2 2692
9 logo_brooklyn.jpg GRAPHIC 97422
10 nt10023650x1_ex4-1image01.jpg GRAPHIC 1183915
11 nt10023650x1_ex5-1image01.jpg GRAPHIC 2277
  Complete submission text file 0001140361-21-015372.txt   2322544
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-255694 | Film No.: 21879734
SIC: 2834 Pharmaceutical Preparations